Apollomics Inc.
APLM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001944885
In the last 90 days, Apollomics Inc. insiders filed 3 open-market purchases and 0 sales; 4 institutions reported holding it in 13F filings for Q2 2026, worth $223.8K in total; no superinvestor holds it.
Other share classesAPLMW
Q2 2023 vs. Q1 2023
How the institutions holding Apollomics Inc. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 8 | 8 | 0 |
| Shares | 1.37M | 1.41M | +38.4K (+2.8%) |
| Value | $33.1M | $8.06M | −$25.1M (−75.7%) |
New holders (4)
Institutions that held Apollomics Inc. at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Exchange Traded Concepts, LLC | 29,552 | $166.1K | 0.00% |
| Levin Capital Strategies, L.P. | 11,000 | $61.8K | 0.01% |
| BlackRock Inc. | 6,562 | $37.6K | 0.00% |
| Advisor Group Holdings, Inc. | 200 | $1.15K | 0.00% |
Sold out (4)
Institutions that held Apollomics Inc. at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Clear Street LLC | 6,800 | $164.6K |
| Wells Fargo & Company | 1,578 | $38.2K |
| UBS Group AG | 414 | $10.0K |
| Tower Research Capital LLC (TRC) | 156 | $4.00K |